Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non–Small Cell Lung Cancer

Patients with CPR tumors exhibit a pre-existing and more mature B cell response that develops further during neoadjuvant ChIO. Our findings link B cell-related features to CPR and highlight BCR metrics as promising predictive biomarkers in NSCLC.